These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28208617)

  • 21. Repression of Noxa by Bmi1 contributes to deguelin-induced apoptosis in non-small cell lung cancer cells.
    Li W; Yu X; Xia Z; Yu X; Xie L; Ma X; Zhou H; Liu L; Wang J; Yang Y; Liu H
    J Cell Mol Med; 2018 Dec; 22(12):6213-6227. PubMed ID: 30255595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of deguelin on the proliferation and apoptosis of human esophageal cancer cell Ec-109: an experimental research].
    Bai ML; Li HJ; Zhang LX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Mar; 33(3):397-400. PubMed ID: 23713258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells.
    Min H; Xu M; Chen ZR; Zhou JD; Huang M; Zheng K; Zou XP
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):167-76. PubMed ID: 24842158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells.
    Peng XH; Karna P; O'Regan RM; Liu X; Naithani R; Moriarty RM; Wood WC; Lee HY; Yang L
    Mol Pharmacol; 2007 Jan; 71(1):101-11. PubMed ID: 17035597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deguelin Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells through Regulating the Expression of Galectin-1.
    Yan B; Zhao D; Yao Y; Bao Z; Lu G; Zhou J
    Int J Biol Sci; 2016; 12(7):850-60. PubMed ID: 27313498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
    He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH
    Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deguelin targets multiple oncogenic signaling pathways to combat human malignancies.
    Tuli HS; Mittal S; Loka M; Aggarwal V; Aggarwal D; Masurkar A; Kaur G; Varol M; Sak K; Kumar M; Sethi G; Bishayee A
    Pharmacol Res; 2021 Apr; 166():105487. PubMed ID: 33581287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway.
    Thamilselvan V; Menon M; Thamilselvan S
    Int J Cancer; 2011 Dec; 129(12):2916-27. PubMed ID: 21472727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological basis and new insights of deguelin concerning its anticancer effects.
    Lin ZY; Yun QZ; Wu L; Zhang TW; Yao TZ
    Pharmacol Res; 2021 Dec; 174():105935. PubMed ID: 34644595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway.
    Bortul R; Tazzari PL; Billi AM; Tabellini G; Mantovani I; Cappellini A; Grafone T; Martinelli G; Conte R; Martelli AM
    Br J Haematol; 2005 Jun; 129(5):677-86. PubMed ID: 15916691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice.
    Murillo G; Kosmeder JW; Pezzuto JM; Mehta RG
    Int J Cancer; 2003 Mar; 104(1):7-11. PubMed ID: 12532413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential.
    Varughese RS; Lam WS; Marican AABH; Viganeshwari SH; Bhave AS; Syn NL; Wang J; Wong AL; Kumar AP; Lobie PE; Lee SC; Sethi G; Goh BC; Wang L
    Cancer; 2019 Jun; 125(11):1789-1798. PubMed ID: 30933320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deguelin induces apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in head and neck squamous cell cancer cell lines.
    Baba Y; Fujii M; Maeda T; Suzuki A; Yuzawa S; Kato Y
    Biomed Res Int; 2015; 2015():657179. PubMed ID: 26075254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GDC-0980-induced apoptosis is enhanced by autophagy inhibition in human pancreatic cancer cells.
    Tang JY; Dai T; Zhang H; Xiong WJ; Xu MZ; Wang XJ; Tang QH; Chen B; Xu M
    Biochem Biophys Res Commun; 2014 Oct; 453(3):533-8. PubMed ID: 25285629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anticancer effect of chaetocin is enhanced by inhibition of autophagy.
    Jung HJ; Seo I; Casciello F; Jacquelin S; Lane SW; Suh SI; Suh MH; Lee JS; Baek WK
    Cell Death Dis; 2016 Feb; 7(2):e2098. PubMed ID: 26890137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis.
    Min C; Zhao Y; Romagnoli M; Trackman PC; Sonenshein GE; Kirsch KH
    J Cell Biochem; 2010 Dec; 111(5):1160-8. PubMed ID: 20717927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement.
    Zhao H; Jiao Y; Zhang Z
    Int J Clin Exp Pathol; 2015; 8(12):15582-90. PubMed ID: 26884827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis.
    Chang DJ; An H; Kim KS; Kim HH; Jung J; Lee JM; Kim NJ; Han YT; Yun H; Lee S; Lee G; Lee S; Lee JS; Cha JH; Park JH; Park JW; Lee SC; Kim SG; Kim JH; Lee HY; Kim KW; Suh YG
    J Med Chem; 2012 Dec; 55(24):10863-84. PubMed ID: 23186287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363.
    Lamoureux F; Thomas C; Crafter C; Kumano M; Zhang F; Davies BR; Gleave ME; Zoubeidi A
    Clin Cancer Res; 2013 Feb; 19(4):833-44. PubMed ID: 23258740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deguelin inhibits expression of IkappaBalpha protein and induces apoptosis of B-CLL cells in vitro.
    Geeraerts B; Vanhoecke B; Vanden Berghe W; Philippé J; Offner F; Deforce D
    Leukemia; 2007 Aug; 21(8):1610-8. PubMed ID: 17568818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.